Eloctate

Product Specs	Description
Manufacturer Name	Sanofi
Description	ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency)
Indications for Adults:
Control and Prevention of Bleeding Episodes	Yes
Perioperative Management	Yes
Routine Prophylaxis to Prevent or Reduce the Frequency of Bleeding Episodes	Yes
Indications for Children:
Control and Prevention of Bleeding Episodes	Yes
Perioperative Management	Yes
Routine Prophylaxis to Prevent or Reduce the Frequency of Bleeding Episodes	Yes
Contraindications Nutrient in Cell Culture	Do not use in patients who have had lifethreatening hypersensitivity reactions, including anaphylaxis, to ELOCTATE or excipients of ELOCTATE.
Stabilizer in Final Formulation	Sucrose, sodium chloride, L-histidine, calcium chloride, and polysorbate 20
Viral Safety Process	Chromatography, detergent treatment, 15 nm filtration
Product Half-Life	Terminal* Half-life (95%CI) >18yrs: 19.7 (17.4,22.0) hours 12-17yrs: 16.4 (14.1, 18.6) hours 6-11yrs: 14.9 (12.0, 17.8) hours 1-5yrs: 12.7 (11.2, 14.1) hours
Product Recovery Percentage Mean incremental recovery IR (IU/dL per IU/kg)	IR (95%CI) >18 yrs: 2.26 (2.13, 2.40) 2.53 ± 0.43
Storage Requirements/Shelf Life	Prior to reconstitution: Store in the original package to protect the vials from light. Store in powder form at 2°C to 8°C (36°F to 46°F). Do not freeze. May be stored at room temperature, not to exceed 30°C (86°F), for a single period of up to 6 months, within the expiration date printed on the label. After storage at room temperature, do not return the product to the refrigerator. Do not use beyond the expiration date printed on the vial. After reconstitution: The reconstituted product may be stored at room temperature, not to exceed 30°C (86°F), for up to 3 hours. Protect from direct sunlight. After reconstitution, if the product is not used within 3 hours, it must be discarded. Do not use if the reconstituted solution is cloudy or has particulate matter.
Nominal Vial Size & Diluent Volume	250, 500, 750, 1000, 1500, 2000, 3000, 4000, 5000, or 6000 IU/3 mL

*Note: Terminal half-life is the time required to divide the plasma concentration by two after reaching pseudo-equilibrium, and not the time required to eliminate half the administered dose. (Toutain PL, et al. J Vet Pharmacoll Ther. 2004.)